[PDF][PDF] Endothelial-to-osteoblast conversion generates osteoblastic metastasis of prostate cancer

SC Lin, YC Lee, G Yu, CJ Cheng, X Zhou, K Chu… - Developmental cell, 2017 - cell.com
SC Lin, YC Lee, G Yu, CJ Cheng, X Zhou, K Chu, M Murshed, NT Le, L Baseler, J Abe
Developmental cell, 2017cell.com
Prostate cancer (PCa) bone metastasis is frequently associated with bone-forming lesions,
but the source of the osteoblastic lesions remains unclear. We show that the tumor-induced
bone derives partly from tumor-associated endothelial cells that have undergone endothelial-
to-osteoblast (EC-to-OSB) conversion. The tumor-associated osteoblasts in PCa bone
metastasis specimens and patient-derived xenografts (PDXs) were found to co-express
endothelial marker Tie-2. BMP4, identified in PDX-conditioned medium, promoted EC-to …
Summary
Prostate cancer (PCa) bone metastasis is frequently associated with bone-forming lesions, but the source of the osteoblastic lesions remains unclear. We show that the tumor-induced bone derives partly from tumor-associated endothelial cells that have undergone endothelial-to-osteoblast (EC-to-OSB) conversion. The tumor-associated osteoblasts in PCa bone metastasis specimens and patient-derived xenografts (PDXs) were found to co-express endothelial marker Tie-2. BMP4, identified in PDX-conditioned medium, promoted EC-to-OSB conversion of 2H11 endothelial cells. BMP4 overexpression in non-osteogenic C4-2b PCa cells led to ectopic bone formation under subcutaneous implantation. Tumor-induced bone was reduced in trigenic mice (Tie2cre/Osxf/f/SCID) with endothelial-specific deletion of osteoblast cell-fate determinant OSX compared with bigenic mice (Osxf/f/SCID). Thus, tumor-induced EC-to-OSB conversion is one mechanism that leads to osteoblastic bone metastasis of PCa.
cell.com